Cell Analysis Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product (Instruments, Consumables and Reagents, Software and Services), By Application (Disease Diagnosis, Biomarker Discovery, Drug discovery, Personalized Medicine, Others), By Techniques (Flow Cytometry, Spectrophotometry, PCR, Next Generation Sequencing, Microscopy, Microarray, Blotting Techniques, Others)  By End User (Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Diagnostic Centres) and Region Forecast 2019-2030

Cell Analysis Market size was valued at US$ 17,500.0 million in 2023 and is poised to grow at a CAGR of 10.4 % from 2024-2030. Cell analysis is to evaluate the fundamental state of the cell, such as the cell's metabolic parameters, cell health, viability, cellular activation, cell-mediated toxicity, cell death, and other parameters, which is helpful in basic research to study disease progression, drug discovery, development, and its clinical application. According to the Centre for Disease Control and Prevention 2020, during COVID-19, RT-PCR was 72.1% more sensitive and 98.7% more specific when compared to the Antigen test.

Moreover, according to a research study in 2023, the clinical application of Flow cytometry is increasing for the identification of leukemia and lymphomas and to enumerate tumorigenic abnormality in cancer patients. The market is flourishing in recent decades due to the increase in the prevalence of viral diseases and has led to increased demand for diagnostic tests like ELISA, PCR, and Electron microscopy. Cell-based assays are the recent trend in drug discovery since they are more accurate when compared to other assays. Strong R&D activities for the development of personalized medicine, advancements in stem cell research, and growing awareness of cell-based therapies are driving the market.

Moreover, a greater understanding of the diagnosis increases in cancer and its types, an increase in the incidence of infectious diseases, and the recent waves of the pandemic have heightened the market in upcoming years. Advances in technology have led to the development of automated cell analysis that delivers accurate and reliable results promptly and reduces the costs associated with manual measurements, and can be used to monitor patients in real-time.

Cell Analysis Market Key Developments 

• In June 2023, Singleron launched two products for developing single-cell multi-omics; NEO-a single-cell sequencing library, and Python Junior-a tissue dissociation instrument that made single-cell sequencing attainable to every laboratory.
• In May 2023, Deepcell launched an AI-powered single-cell analysis platform to catalyze the field of Morpholomics and accelerate discovery in cell biology.
• In March 2023, Atrandi Biosciences secured funding of a total of $8 million from Vsquared Ventures, Practica Capital and Metaplanet for the commercialization of a new semi-permeable capsule technology; a Next-Gen Single-cell analysis Technology.